ESCOZINE GNP-1

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameESCOZINE GNP-1

Drug Alias NameEscozinemedical grade Escozine (Medolife)

ClassificationBiologics > Protein drugs > Recombinant polypeptide

Mechanisms of ActionCyclooxygenase-2 inhibitors

TargetsCyclooxygenase-2

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesDominican Republic

CombinationsNo

Global Highest StatusClinical

Highest Status in ChinaN/A

Originator CompaniesMedolife Rx Inc

China Registration ClassN/A

Active CompaniesMedolife Rx Inc

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)Neoplasms

Inactive IndicationsN/A

ATC CodeN/A